Navigation Links
Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
Date:3/31/2008

r materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to: (i) the risk that our APTIMA HPV assay will perform poorly in this clinical trial, (ii) the risk that the APTIMA HPV assay will not be cleared for marketing in the timeframe we expect, if at all, (iii) the possibility that the market for the sale of our APTIMA HPV assay may not develop as expected, (iv) we may not be able to compete effectively with other companies already selling HPV diagnostic products or which launch such products in the future, (v) we depend on a small number of contract manufacturers and single source suppliers of raw materials, (vi) changes in third-party reimbursement policies regarding our products could adversely affect their sales, (vii) changes in government regulation affecting our products could harm our sales and increase our development costs, and (viii) litigation involving the assertion of third party patent rights could be expensive and divert management's attention, and/or result in damages or injunctive relief. The foregoing describes some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

Contact:

Michael Watts

Senior director, investor relations and

corporate communications

<
'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
8. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
(Date:8/21/2014)...  Aptuit LLC announces that Aptuit SSCI, located ... has enhanced its capabilities in the areas of ... molecules, including biologic drugs, metabolites, and polymers, through ... spectrometer. In making the announcement, Dr. ... expanded large molecule capability enhances our early development ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... Corporation, a leading provider of powered toilet lifts for ... today a new white paper that details a return-on-investment ... financial impact of using powered toilet lifts in support ... The white paper was introduced at the 12th Annual ...
... -- Global Information Inc. is excited to announce ... 8th Annual World Health Care Congress - Europe ... healthcare systems may be diverse, but the all share many ... health systems across the entire world, and many nations are ...
Cached Medicine Technology:New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting-Related Falls in Healthcare Facilities 28th Annual World Health Care Congress Set for Amsterdam, Spring 2012 2
(Date:8/22/2014)... children have a higher-than-normal risk of developing food allergies, a ... in four U.S. cities -- Baltimore, Boston, New York and ... that at least 10 percent of them developed an allergy ... most common types of food allergies were included in the ... allergies may be even higher, the researchers said. Overall, ...
(Date:8/22/2014)... severe disabilities and multiple chronic conditions are screened for ... or no chronic conditions, a new study has found. ... with moderate disabilities or women with only one chronic ... with the Li Ka Shing Knowledge Institute of St. ... often have other measures of social vulnerability, such as ...
(Date:8/22/2014)... 22, 2014 Key West Health & ... revealed their much anticipated study results of the 12 ... and released an accompanying infographic on their website. It ... have a major impact on the skin and contribute ... more. , When asked how they determined the results, ...
(Date:8/22/2014)... Until now, those with leg or foot ... to keep mobile. Thanks to an inventor from Suffolk, Va., ... , He developed a prototype for the patent-pending SUPPORT AID ... foot but provide comfort and reduce pain for those using ... is also convenient and easy to install on the crutch ...
(Date:8/22/2014)... difficulties, fainting. Each year approx. 265,000 Danes are acutely ... New research from Aarhus University and Aarhus University Hospital ... as every fourth patient are sent home again ... led to the acute hospitalisation., "Naturally, there is no ... hospital disprove that there is a serious illness. So ...
Breaking Medicine News(10 mins):Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Many patients are discharged without a diagnosis 2
... as likely as white patients to receive therapy, study ... patients with heart disease are only half as likely ... a Duke University Medical Center study. , "This is ... associated with a 2- to 4-fold increase in the ...
... not rated high in survey , , WEDNESDAY, Oct. 29 ... not satisfied with their care, Harvard researchers report. , ... hospitals were found wanting in key areas such as ... of patients gave low ratings to pain management, and ...
... to Match Physicians with Hiring Organizations to Save You Time ... ... California (PRWEB) October 29, 2008 -- MedMatcher, Inc. today announced ... provide physicians a simple solution to find the perfect physician ...
... housing opportunities ... statewide, ... and support services professionals gathered,in Duluth for Heading Home Minnesota,s Marking ... housing,opportunities with support services for Minnesota individuals and families,who are homeless., ...
... has announced the,launch of an ongoing series of ... for managing the changing healthcare,landscape. The first in ... Pharmacy, will convene Wednesday evening,October 29, at the ... run,through Thursday, October 30, 2008., This invitation-only ...
... or not, we all experience memory errors from time to ... result of having too many other things to remember or ... have indicated that a specific type of false memory known ... a mistake that we often make when recalling a view ...
Cached Medicine News:Health News:Black Heart Patients Treated Less for Depression 2Health News:U.S. Hospitals Lag in Patient Satisfaction 2Health News:U.S. Hospitals Lag in Patient Satisfaction 3Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 2Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 3Health News:Minnesota Reaches Milestone in Goal to End Homelessness 2Health News:NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 2Health News:NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 3Health News:Our cheatin' brain: The brain's clever way of showing us the world as a whole 2
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
OES Pro Optical Urethrotome...
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
... line combines market-leading optical ... durable hardware. The color-coded ... robust, ergonomic design and ... on Stryker endoscopes. The ...
Medicine Products: